Abstract
Schneiderian papilloma (SP) are uncommon tumors with malignant transformation even less common. The histologic criteria to define malignant transformation are not well developed nor is the immunohistochemical profile reported in a large series of carcinomas. 20 cases of malignant transformation of SP included 7 females and 13 males, aged 38–86 years (mean 60.7 years). Patients presented most frequently with a mass (n = 11) and obstructive symptoms (n = 7), present for 38.7 months (mean). Most patients had no previous history of SP (n = 13); metachronous carcinoma was identified in 7 patients an average of 34.4 months after the first diagnosis of SP, with 1–4 recurrences of SP. With a mean size of 4.1 cm, the majority of tumors involved a combination of more than one anatomic site (n = 10), followed by the maxillary sinus only (n = 5) or nasal cavity only (n = 3). Histologically, 17 were inverted and 3 exophytic type SP. There were 17 squamous cell carcinomas, 2 mucoepidermoid carcinomas and 1 sinonasal undifferentiated carcinoma, comprising from 10 to 95 % of the tumor volume. Malignant histologic features included atypical mitoses, necrosis, bone invasion, lymphovascular invasion, decreased transmigrating neutrophils, paradoxical maturation, dyskeratosis and/or perineural invasion (n = 3). Patients tended to present with advanced stage (n = 14, Stage III and IV). Immunohistochemical studies showed positive reactions in the malignancies for CK5/6 (86 %), p63 (86 %), CK7 (luminal, 50 %), p53 (83 %), and p16 (25 %). In situ hybridization detected human papillomavirus in 26 %. Surgery was often accompanied by radiation therapy (n = 13), with a mean of 2.4 years of follow-up. Five patients developed a recurrence between 0.8 and 3.3 years. Carcinomas ex-SP are less common and are associated with better outcome than previously reported. Patients tend to present with a synchronous carcinoma, developing in an inverted type SP, with squamous cell carcinoma the most common malignancy. Development of metachronous carcinomas ex-SP was always preceded by SP recurrence in this series.
Similar content being viewed by others
References
AJCC Cancer Staging Manual, 7th ed. New York: Springer; 2009.
Buchwald C, Franzmann MB, Jacobsen GK, Juhl BR, Lindeberg H. Carcinomas occurring in papillomas of the nasal septum associated with human papilloma virus (HPV). Rhinology. 1997;35:74–8.
Dingle I, Stachiw N, Bartlett A, Lambert P. Bilateral inverted papilloma of the middle ear with intracranial involvement and malignant transformation: first reported case. Laryngoscope. 2012;122:1615–9.
Dolgin SR, Zaveri VD, Casiano RR, Maniglia AJ. Different options for treatment of inverting papilloma of the nose and paranasal sinuses: a report of 41 cases. Laryngoscope. 1992;102:231–6.
Halimi M, Aghbali A, Emamverdizadeh P, Talesh KT. Inverted papilloma of the palate with malignant transformation. J Oral Maxillofac Pathol. 2012;16:291–3.
Kapadia SB, Barnes L, Pelzman K, Mirani N, Heffner DK, Bedetti C. Carcinoma ex oncocytic Schneiderian (cylindrical cell) papilloma. Am J Otolaryngol. 1993;14:332–8.
Klemi PJ, Joensuu H, Siivonen L, Virolainen E, Syrjanen S, Syrjanen K. Association of DNA aneuploidy with human papillomavirus-induced malignant transformation of sinonasal transitional papillomas. Otolaryngol Head Neck Surg. 1989;100:563–7.
Kobylecki C, Gnanalingham KK, Soh C, Du Plessis D, Hamdalla HH. Malignant transformation of a Schneiderian papilloma presenting with isolated sixth nerve palsy. Br J Neurosurg. 2013;27:262–3.
Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope. 1995;105:178–83.
Maitra A, Baskin LB, Lee EL. Malignancies arising in oncocytic Schneiderian papillomas: a report of 2 cases and review of the literature. Arch Pathol Lab Med. 2001;125:1365–7.
Norris HJ. Papillary lesions of the nasal cavity and paranasal sinuses. I. Exophytic (squamous) papillomas. A study of 28 cases. Laryngoscope. 1962;72:1784–97.
Norris HJ. Papillary lesions of the nasal cavity and paranasal sinuses. II. Inverting papillomas. A study of 29 cases. Laryngoscope. 1963;73:1–17.
Snyder RN, Perzin KH. Papillomatosis of nasal cavity and paranasal sinuses (inverted papilloma, squamous papilloma). A clinicopathologic study. Cancer. 1972;30:668–90.
Terada T. Malignant transformation of exophytic Schneiderian papilloma of the nasal cavity. Pathol Int. 2012;62:199–203.
Vayisoglu Y, Unal M, Apa DD, Gucluturk MT. Schneiderian carcinoma developing in an inverted papilloma of the palatine tonsil: an unusual case. Ear Nose Throat J. 2011;90:E32–4.
Vrabec DP. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope. 1994;104:582–605.
Ward BE, Fechner RE, Mills SE. Carcinoma arising in oncocytic Schneiderian papilloma. Am J Surg Pathol. 1990;14:364–9.
Beck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE, Bradford CR. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg. 1995;113:558–63.
Bielamowicz S, Calcaterra TC, Watson D. Inverting papilloma of the head and neck: the UCLA update. Otolaryngol Head Neck Surg. 1993;109:71–6.
Abildgaard-Jensen J, Greisen O. Inverted papillomas of the nose and the paranasal sinuses. Clin Otolaryngol Allied Sci. 1985;10:135–43.
Christensen WN, Smith RR. Schneiderian papillomas: a clinicopathologic study of 67 cases. Hum Pathol. 1986;17:393–400.
Furuta Y, Shinohara T, Sano K, Nagashima K, Inoue K, Tanaka K, et al. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1991;101:79–85.
Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol. 1971;80:192–206.
Lasser A, Rothfeld PR, Shapiro RS. Epithelial papilloma and squamous cell carcinoma of the nasal cavity and paranasal sinuses: a clinicopathological study. Cancer. 1976;38:2503–10.
Lawson W, Kaufman MR, Biller HF. Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases. Laryngoscope. 2003;113:1548–56.
Myers EN, Fernau JL, Johnson JT, Tabet JC, Barnes EL. Management of inverted papilloma. Laryngoscope. 1990;100:481–90.
Outzen KE, Grontved A, Jorgensen K, Clausen PP. Inverted papilloma of the nose and paranasal sinuses: a study of 67 patients. Clin Otolaryngol Allied Sci. 1991;16:309–12.
Pelausa EO, Fortier MA. Schneiderian papilloma of the nose and paranasal sinuses: the University of Ottawa experience. J Otolaryngol. 1992;21:9–15.
Phillips PP, Gustafson RO, Facer GW. The clinical behavior of inverting papilloma of the nose and paranasal sinuses: report of 112 cases and review of the literature. Laryngoscope. 1990;100:463–9.
Ridolfi RL, Lieberman PH, Erlandson RA, Moore OS. Schneiderian papillomas: a clinicopathologic study of 30 cases. Am J Surg Pathol. 1977;1:43–53.
Segal K, Atar E, Mor C, Har-El G, Sidi J. Inverting papilloma of the nose and paranasal sinuses. Laryngoscope. 1986;96:394–8.
Shah AA, Evans MF, Adamson CS, Peng Z, Rajendran V, Cooper K. HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16(INK4a) immunoreactivity. Head Neck Pathol. 2010;4:106–12.
Skolnik EM, Loewy A, Friedman JE. Inverted papilloma of the nasal cavity. Arch Otolaryngol. 1966;84:61–7.
Weissler MC, Montgomery WW, Turner PA, Montgomery SK, Joseph MP. Inverted papilloma. Ann Otol Rhinol Laryngol. 1986;95:215–21.
Woodson GE, Robbins KT, Michaels L. Inverted papilloma. Considerations in treatment. Arch Otolaryngol. 1985;111:806–11.
Barnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002;15:279–97.
Kaufman MR, Brandwein MS, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic Schneiderian papillomas. Laryngoscope. 2002;112:1372–7.
Kristensen S, Vorre P, Elbrond O, Sogaard H. Nasal Schneiderian papillomas: a study of 83 cases. Clin Otolaryngol Allied Sci. 1985;10:125–34.
Lawson W, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope. 1995;105:282–8.
Nachtigal D, Yoskovitch A, Frenkiel S, Braverman I, Rochon L. Unique characteristics of malignant Schneiderian papilloma. Otolaryngol Head Neck Surg. 1999;121:766–71.
Wenig BM. Schneiderian-type mucosal papillomas of the middle ear and mastoid. Ann Otol Rhinol Laryngol. 1996;105:226–33.
Eggers G, Eggers H, Sander N, Kossling F, Chilla R. Histological features and malignant transformation of inverted papilloma. Eur Arch Otorhinolaryngol. 2005;262:263–8.
Katori H, Nozawat A, Tsukuda M. Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal-inverted papilloma. Clin Oncol (R Coll Radiol). 2006;18:300–5.
Fan GK, Imanaka M, Yang B, Takenaka H. Characteristics of nasal inverted papilloma and its malignant transformation: a study of cell proliferation and programmed cell death. Am J Rhinol. 2006;20:360–3.
Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol. 2005;31:905–11.
Tufano RP, Mokadam NA, Montone KT, Weinstein GS, Chalian AA, Wolf PF, et al. Malignant tumors of the nose and paranasal sinuses: hospital of the University of Pennsylvania experience 1990–1997. Am J Rhinol. 1999;13:117–23.
Katori H, Nozawa A, Tsukuda M. Cell proliferation, apoptosis, and apoptosis inhibition in malignant transformation of sinonasal inverted papilloma. Acta Otolaryngol. 2007;127:540–6.
Acknowledgments
The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of Southern California Permanente Medical Group or the University of Pittsburgh.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nudell, J., Chiosea, S. & Thompson, L.D.R. Carcinoma Ex-Schneiderian Papilloma (Malignant Transformation): A Clinicopathologic and Immunophenotypic Study of 20 Cases Combined with a Comprehensive Review of the Literature. Head and Neck Pathol 8, 269–286 (2014). https://doi.org/10.1007/s12105-014-0527-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-014-0527-7